Name | tert-Butyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)carbamate |
---|---|
Synonyms |
[5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)- pyridin-3-yl]-carbamic acid tert-Butyl ester
tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ylcarbamate Carbamic acid, N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]-, 1,1-dimethylethyl ester 2-Methyl-2-propanyl [5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]carbamate |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 400.7±30.0 °C at 760 mmHg |
Molecular Formula | C16H25BN2O4 |
Molecular Weight | 320.192 |
Flash Point | 196.1±24.6 °C |
Exact Mass | 320.190735 |
PSA | 69.68000 |
LogP | 2.80080 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.504 |
Hazard Codes | Xi |
---|
~68% 1171897-39-4 |
Literature: PETER MACCALLUM CANCER INSTITUTE; SPICER, Julie Ann; DENNY, William Alexander; MILLER, Christian Karl; O'CONNOR, Patrick David; HUTTUNEN, Kristiina; TRAPANI, Joseph A.; HILL, Geoff; ALEXANDER, Kylie Patent: WO2014/28968 A1, 2014 ; Location in patent: Page/Page column 102 ; |
~% 1171897-39-4 |
Literature: WO2011/28741 A1, ; WO 2011/028741 A1 |
~% 1171897-39-4 |
Literature: WO2011/28741 A1, ; WO 2011/028741 A1 |
Precursor 4 | |
---|---|
DownStream 0 |